Literature DB >> 6245143

From the center for disease control. Epidemiology of pneumococcal serotypes in the United States, 1978--1979.

C V Broome, R R Facklam, J R Allen, D W Fraser, R Austrian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6245143     DOI： 10.1093/infdis/141.1.119

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  16 in total

1.  Pneumococcal peptidoglycan-polysaccharides regulate Toll-like receptor 2 in the mouse middle ear epithelial cells.

Authors:  Masahiro Komori; Yoshihisa Nakamura; Jesse Ping; Ling Feng; Katsuhiro Toyama; Youngki Kim; Patricia Ferrieri; Jizhen Lin
Journal:  Pediatr Res       Date:  2011-02       Impact factor: 3.756

2.  Predicting cost-benefits before programs are started: looking at conjugate vaccine for invasive pneumococcal infections.

Authors:  W J Hueston; A G Mainous; N Brauer
Journal:  J Community Health       Date:  2000-02

Review 3.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

4.  Distribution of serotypes of Streptococcus pneumoniae isolated from invasive infections over a 16-year period in the greater São Paulo area, Brazil.

Authors:  M C Brandileone; V S Vieira; R C Zanella; I M Landgraf; C E Melles; A Taunay; J C de Moraes; R Austrian
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

5.  Pneumococcal antibody levels in patients with acute lung infiltrates.

Authors:  A Löwenberg; J A Snijder; L T vd Weele; H J Sluiter
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

6.  Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers.

Authors:  S C Szu; C J Lee; J C Parke; G Schiffman; J Henrichsen; R Austrian; S C Rastogi; J B Robbins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

7.  A comparison of the distribution of pneumococcal types in systemic disease and the upper respiratory tract in adults and children.

Authors:  L E Smart; D J Platt; M C Timbury
Journal:  Epidemiol Infect       Date:  1987-04       Impact factor: 2.451

8.  Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination.

Authors:  J H Braconier; E B Myhre; H Odeberg
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

9.  Pneumococcal serotypes causing bacteremia and meningitis: relevance to composition of pneumococcal vaccine.

Authors:  J M Dixon; A E Lipinski
Journal:  Can Med Assoc J       Date:  1981-08-01       Impact factor: 8.262

10.  Bacterial meningitis in Egypt: analysis of CSF isolates from hospital patients in Cairo, 1977-78.

Authors:  N Guirguis; K Hafez; M A El Kholy; J B Robbins; E C Gotschlich
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.